Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amebic Liver Abscess.

Wolfram Goessling1, Raymond T. Chung

  • 1Gastrointestinal Unit, Jackson 8, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA. rhchung@partners.org

Current Treatment Options in Gastroenterology
|November 1, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hierarchical organ aging signatures from routine abdominal CT add incremental disease risk stratification beyond blood biomarkers.

medRxiv : the preprint server for health sciences·2026
Same author

Cardiovascular and Cardiometabolic Outcomes in Adults with Fetal Alcohol Spectrum Disorders: A Retrospective Cohort Study.

medRxiv : the preprint server for health sciences·2026
Same author

Single-nucleus ATAC-seq analysis resolves chromatin and transcriptional features of fibrolamellar carcinoma.

Scientific reports·2026
Same author

Bnip3lb-driven mitophagy maintains fate of the embryonic hematopoietic stem cell pool.

Nature communications·2026
Same author

Hepatic adaptation to chronic metabolic stress primes tumorigenesis.

Cell·2025
Same author

A tribute to Richard L. Maas (1954-2025).

The Journal of clinical investigation·2025
Same journal

Esophageal Disorders in the Older Adult.

Current treatment options in gastroenterology·2025
Same journal

Endobariatrics: a Still Underutilized Weight Loss Tool.

Current treatment options in gastroenterology·2023
Same journal

Management of Post Ablative Barrett's Esophagus: a Review of Current Practices and Look at Emerging Technologies.

Current treatment options in gastroenterology·2023
Same journal

Inflammatory Bowel Disease Therapy and Venous Thromboembolism.

Current treatment options in gastroenterology·2023
Same journal

Ileal Pouch-Anal Anastomosis in the Older Adult: a Review of Postoperative Outcomes and Pouchitis Treatment.

Current treatment options in gastroenterology·2023
Same journal

Celiac Disease in the Elderly.

Current treatment options in gastroenterology·2023
See all related articles

Amebic liver abscess requires prompt treatment with metronidazole, followed by paromomycin to eliminate cysts. Early diagnosis and therapy are crucial for travelers and immunocompromised individuals to prevent severe complications.

Area of Science:

  • Infectious Diseases
  • Hepatology
  • Parasitology

Background:

  • Amebic liver abscess (ALA) is a significant concern in travelers from endemic regions and immunocompromised individuals.
  • Clinical presentation includes fever, right upper quadrant pain, hepatomegaly, and imaging findings suggestive of a liver lesion.
  • Prompt diagnosis and treatment are essential to prevent complications.

Purpose of the Study:

  • To outline the diagnostic considerations and therapeutic strategies for amebic liver abscess.
  • To emphasize the importance of timely intervention and appropriate drug selection.
  • To discuss management options for refractory cases and the potential role of vaccines.

Main Methods:

  • Review of clinical presentation and diagnostic criteria for ALA.

Related Experiment Videos

  • Description of standard medical therapy, including metronidazole and a luminal antiamebic agent.
  • Outline of indications for image-guided drainage and surgery.

    • Main Results:

    • Metronidazole provides rapid symptomatic relief in most patients within 2-3 days.
    • Metronidazole has limited efficacy against luminal cysts (50%), necessitating follow-up treatment with paromomycin.
    • Image-guided drainage and surgery are reserved for specific clinical scenarios.

    Conclusions:

    • Medical management with metronidazole followed by a luminal agent is the mainstay of ALA treatment.
    • Aggressive management, including drainage or surgery, is indicated for non-responders or complicated cases.
    • Development of vaccines is crucial for the global eradication of Entamoeba histolytica infection.